Plant Health Care protects crops by stimulating their immune system

Plant Health Care is a leading provider of scientifically proven biological products for the agricultural industry. The company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, cotton and rice, as well as specialty crops such as fruits and vegetables.

Our innovative line of patent protected products provides both economic and environmental benefits for our customers and capitalizes upon long-term trends towards natural systems and biological solutions to promote plant health and growth.

(, ) forecast a strong second half of 2021 and says it will achieve material revenue growth for the full year.

The biological products developer also unveiled a new partnership with Nutrien Ag Solutions to launch its novel Saori soybean seed treatment in Brazil, the world’s largest producer of this pea.

Asian soybean rust, caused by the fungus Phakopsora pachyrhizi, is a disease that can lead to a crop yield loss of up to 90%. Brazilian soybean farmers spent US$2.85bn on disease control in the 2019/20 season.

The AIM-listed group is also preparing for the first launches of PHC279, tapping a market estimated to reach US$5bn.

(, ) announced Argentina has approved its Harpin ab product for use as a seed treatment.

Senasa, the country’s food safety regulator, classified it as a biostimulant organic-chemical fertiliser. Corn and soybeans will be the first crops allowed to receive Harpin.

() has landed a new distribution agreement with Agrii, described as a leading distributor in the UK, which gains exclusive access to the company’s biostimulant, Harpin ?, in all crops in the UK.

The company said that Harpin ? has exceptional grower benefits for those in the UK, particularly in the amenity (turf) market and in potatoes. It has been sold on a small scale in the UK previously, under the ProAct brand name.

() is one of those innovators that has thus far flown below the market’s radar – but for how long?

Its technologies are designed to “stimulate the immune system of plants,” says chief executive, Dr Christopher Richards, trying to keep things reasonably high level for me. “Think of them as vaccines for plants,” he continues.

()’s () Christopher Richards talks to Proactive London’s Katie Pilbeam about their plans to commence trading on the US OTCQB Venture Market which he says is ‘start of something very exciting’.

Richards explains how the US market represents the single largest opportunity for Plant Health Care products.

He also discusses their first-half sales of their lead product as ‘encouraging’ with revenue for the six months ended June 30 was up 13% at U$3.5mln.